Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor backend or formatting update to the page. No study content, eligibility criteria, or results appear to be altered by this revision.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 for the study page. This reflects an administrative update to the ClinicalTrials.gov record rather than a change to the trial itself.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 as the page’s version label, indicating a minor backend/template update. It does not alter the study data, eligibility criteria, outcomes, or other user-visible content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded related disease term familial multiple polyposis syndrome and an external resource link to the Genetic and Rare Diseases Information Center for additional context.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.